Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
IFNK
(Interferon, kappa (IFNK))
Andere Bezeichnung
IFNK
Hintergrund
Interferon kappa, IFN-kappaIFNK (Interferon Kappa) is a Protein Coding gene. Diseases associated with IFNK include Skin Conditions and Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1. Among its related pathways are RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways and Jak-STAT signaling pathway (KEGG). IFNK encodes a member of the type I interferon family. Type I interferons are a group of related glycoproteins that play an important role in host defenses against viral infections. This protein is expressed in keratinocytes and the gene is found on chromosome 9, adjacent to the type I interferon cluster.